share_log

綠葉製藥:自願性公告 - 利斯的明透皮貼劑(2次/W)在中國獲批上市

LUYE PHARMA: VOLUNTARY ANNOUNCEMENT - RIVASTIGMINE TWICE WEEKLY TRANSDERMAL PATCH APPROVED FOR MARKETING IN CHINA

香港交易所 ·  Oct 31, 2023 06:21
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more